Decoy Therapeutics files prospectus for resale of up to 2,368,868 shares
Decoy Therapeutics filed a prospectus for the resale of up to 2,368,868 common shares, according to an SEC filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.